About VNIR
VNIR is a Healthcare company based in Bengaluru (India) founded in 2017 by Meher Kiran Prakash Ayalasomayajula and Thimmaiah Govindaraju. Infrared fluorescence-based diagnostic molecules are developed for imaging. VNIR has raised $724.46 thousand across 5 funding rounds from investors including Startup Karnataka, Venkata Prashanth Gangu and Hari P Thadakamalla. VNIR was last valued at $4.28 million in November 2021. Its Indian entity Vnir Biotechnologies Private Limited reported revenue of ₹36.6 Lakh. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Radioisotopes.
Company details
VNIR was founded in 2017 in Bengaluru, India, within the biotechnology sector. Infrared fluorescence-based imaging and diagnostic molecules are developed by the company for applications in live-cell imaging and early detection of conditions such as Alzheimers disease, malaria, and kidney failure. Probes that absorb green light and emit red light are utilized in ROS staining, mitochondria staining, and plant protoplast staining.
- Headquarters Bengaluru, India
- Founders Meher Kiran Prakash Ayalasomayajula, Thimmaiah Govindaraju
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website vnir.life
- Social LinkedIn X Facebook Instagram
- Legal Name Vnir Biotechnologies Private Limited
- Date of Incorporation 11 Apr, 2017
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹36.6 Lakh
FY 2025 · -37% YoY
- Net Loss-₹40.9 Lakh
FY 2025 · -112% margin
- EBITDA-₹22.6 Lakh
FY 2025 · -62% margin
- Total Equity Funding$724.46K (USD)
in 5 rounds
- Latest Funding Round$284.98K (USD), Angel Round
Nov 2021
- InvestorsStartup Karnataka
& 37 more
Associated legal entities of VNIR
VNIR operates through Vnir Biotechnologies Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Vnir Biotechnologies Private Limited CIN U73200KA2017PTC102171 | Active | 11 Apr 2017 | Bangalore, Karnataka | ₹0.4 Cr | 3 | View details |
Funding Insights of VNIR
VNIR has successfully raised a total of $724.46K across 5 strategic funding rounds. The most recent funding activity was a Angel Round of $284.98 thousand completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $724,462
- Total Rounds 5
- Last Round Angel Round — $284,975
- Investors Count 38
All 5 funding rounds of VNIR with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2021 | $284,975 | Angel Round | $4.28M | Venkata Prashanth Gangu, Venkata Prashanth Gangu | |
| Mar 2021 | $354,272 | Angel Round | $3.65M | Rahul A Vasudeva Rao, Mahesh Tudur Channappa | |
| Jan 2019 | $42,509 | Angel Round | $••••• | Laxmi Narsamma Gangu | |
| Aug 2018 | $42,706 | Angel Round | $••••• | Vijay Chandru | |
| Aug 2017 | Grant | – | – |
| Date | Valuation | Stage |
|---|---|---|
| Nov 2021 | $4.28M | •••••••• |
| Mar 2021 | $3.65M | •••••••• |
| Jan 2019 | $••••• | •••••••• |
| Aug 2018 | $••••• | •••••••• |
Full valuation and stage history of VNIR
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $4.28M (Nov 2021). 38 investors in total: 1 institutional and 37 angel.
Investors in VNIR
VNIR has secured backing from 38 investors, including angel and institutional investors. Prominent investors backing the company include Startup Karnataka, Venkata Prashanth Gangu and Hari P Thadakamalla.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Support for startups in Karnataka is delivered through policies, funding, and networking services. | 2004 | missionstartupkarnataka.org | Bengaluru, India | |
VP Venkata Prashanth Gangu | unknown_0a831b566a3a496fb | |||
HP Hari P Thadakamalla | unknown_e615d77c63b54d7db | |||
AR Arvind Reddy Battula | unknown_f4f531595f9a4c1eb | |||
JB Jagadish B Mendu | unknown_ffff07c32dff485ba | |||
AK Anil Kamarajugadda | unknown_c0a977371e4c44299 | |||
BK Bhagat Kota | unknown_7baff179f224446d8 | |||
SV Satish Vedantam | unknown_59c1fc55f07d4c27a | |||
CK Chandra Kiran Maddukuri | unknown_30dead4cc4c64b9d9 | |||
VP Venkata Prashanth Gangu | unknown_e9391c99c398414aa |
Investor details for VNIR
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Vnir Biotechnologies Private Limited (VNIR)
Vnir Biotechnologies Private Limited is the primary company behind VNIR. The board of Vnir Biotechnologies Private Limited currently have 3 directors; the longest-serving is Govindaraju Thimmaiah, appointed in 2017. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Govindaraju Thimmaiah DIN 07744954 | Director | 11 Apr 2017 | 9 yrs 7 mo | Vnir Biotechnologies Private Limited |
| Meher Kiran Prakash Ayalasomayajula DIN 07753129 | Director | 11 Apr 2017 | 9 yrs 7 mo | Vnir Biotechnologies Private Limited |
| Jagadeesh Ramanna . Daler DIN 10238303 | Director | 10 Aug 2023 | 3 yrs 3 mo | Vnir Biotechnologies Private Limited |
People of VNIR
2 people are tracked at VNIR (2 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder | Leadership | |
| Co-Founder | Leadership |
Complete people profiles for VNIR
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of VNIR
Figures of Vnir Biotechnologies Private Limited, the primary company behind VNIR, for FY 2025. Revenue was ₹36.6 Lakh (-37% year on year). Net loss was -₹40.9 Lakh (-112% margin). EBITDA was -₹22.6 Lakh (-62% margin). Revenue has grown at a compounded annual rate of +39% over three years and +31% over five years.
- ₹36.6 LakhRevenue · FY 2025 · -37% YoY
- -₹40.9 LakhNet loss · -112% margin
- -₹22.6 LakhEBITDA · -62% margin
- ₹1.2 LakhPaid-up capital
- +39%Revenue CAGR, 3 years
- +31%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Vnir Biotechnologies Private Limited are on its company page.
Detailed financial statements for VNIR
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of VNIR
4 dated milestones of VNIR across 4 years, from founding to its latest funding, stage changes and deals.
- Founded VNIR is founded.
- Funding First funding round.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Angel Round, of $285K.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Vnir
Complete news archive for VNIR
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about VNIR
VNIR was founded in 2017.
VNIR is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
VNIR is a funded company, having raised a total of $724.46K across 5 funding rounds to date.
The primary company behind VNIR, Vnir Biotechnologies Private Limited, reported revenue of ₹36.6 Lakh for FY 2025, down 37% year on year.
VNIR was founded in 2017 in Bengaluru, India, within the biotechnology sector. Infrared fluorescence-based imaging and diagnostic molecules are developed by the company for applications in live-cell imaging and early detection of conditions such as Alzheimers disease, malaria, and kidney failure. Probes that absorb green light and emit red light are utilized in ROS staining, mitochondria staining, and plant protoplast staining.
VNIR has 38 investors. Key investors include Startup Karnataka, Venkata Prashanth Gangu, Hari P Thadakamalla, Arvind Reddy Battula, and Jagadish B Mendu.
The valuation of VNIR is $4.28M as of Nov 2021.
VNIR operates through Vnir Biotechnologies Private Limited.
The legal entities of VNIR currently have 3 directors, including Govindaraju Thimmaiah, Jagadeesh Ramanna . Daler, Meher Kiran Prakash Ayalasomayajula.